Results 181 to 190 of about 4,776,663 (339)

Toxic interstitial lung disease in cattle. [PDF]

open access: yesJ Vet Diagn Invest
Barros CSL   +3 more
europepmc   +1 more source

Validation of the 8th edition of the TNM staging system in 3,950 patients with surgically resected non-small cell lung cancer

open access: diamond, 2019
Jae Kwang Yun   +6 more
openalex   +1 more source

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity

open access: yesMolecular Oncology, EarlyView.
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek   +2 more
wiley   +1 more source

Post-lobectomy lung abscess. [PDF]

open access: yesJ Surg Case Rep
Kim SE   +4 more
europepmc   +1 more source

Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer [PDF]

open access: bronze, 2006
Junichi Soh   +12 more
openalex   +1 more source

Lactoferrin treatment activates acetylcholinesterase, decreasing acetylcholine levels in non‐small cell lung cancer (NSCLC) cell culture supernatants, inhibiting cell survival

open access: yesFEBS Open Bio, EarlyView.
Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel   +9 more
wiley   +1 more source

Lung cancer: An organized cellular and metabolic domain [PDF]

open access: bronze, 2007
Michael I. Koukourakis   +3 more
openalex   +1 more source

Indoleamine 2,3‐dioxygenase 1 inhibition reverses cancer‐associated fibroblast‐mediated immunosuppression in high‐grade serous ovarian cancer

open access: yesFEBS Open Bio, EarlyView.
CAF‐mediated immunosuppression in ovarian cancer is driven by IDO1, reducing T‐cell function. Inhibiting IDO1 restores T‐cell proliferation and cytotoxicity, increases cancer cell apoptosis, and may help overcome CAF‐induced immune suppression in high‐grade serous ovarian cancer. Targeting IDO1 may improve antitumor immunity.
Hyewon Lee   +3 more
wiley   +1 more source

Advancing Lung Cancer Care in Bulgaria: A Successful Implementation of Value-Based Healthcarе. [PDF]

open access: yesJ Patient Exp
Vutova Y   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy